Ultrahuman brings affordable continuous glucose monitoring to US consumers

By Moinak Pal Published June 18, 2026

Ultrahuman has announced the launch of M2 Live in the United States, expanding access to continuous glucose monitoring and metabolic health insights for consumers without diabetes. The new platform integrates glucose data from Abbott’s over-the-counter Lingo continuous glucose monitor (CGM), allowing users to track their metabolic health without requiring a prescription.

The launch represents a significant step for the company, which helped popularize glucose monitoring for wellness-focused consumers when it introduced its first metabolic tracking platform in 2021. With M2 Live, Ultrahuman is aiming to make the technology more affordable and accessible, with subscriptions starting at $99 per month and individual sensors priced at $129.

The company says the platform is designed for adults looking to better understand how food, exercise, stress, and sleep affect their bodies in real time. It is also available to people with prediabetes who are interested in improving their overall metabolic health.

Unlike traditional glucose monitoring solutions that focus solely on blood sugar levels, M2 Live combines glucose data with other health metrics to provide a more comprehensive picture of wellness.

The platform integrates information from Abbott’s Lingo biosensor with data collected from the Ultrahuman Ring and the company’s Blood Vision service, which analyzes more than 100 blood biomarkers. This allows users to view glucose patterns alongside sleep quality, activity levels, recovery, stress, heart rate variability, and body temperature.

Powering the experience is Jade AI, Ultrahuman’s real-time biointelligence engine. The system analyzes health data and helps explain why glucose levels rise or fall by connecting them to lifestyle factors such as meals, exercise routines, sleep habits, and recovery patterns.

M2 Live also includes several tools designed to make glucose data easier to understand. These include a daily Metabolic Score ranging from 0 to 100, personalized Food Scores that show how specific foods affect glucose levels, real-time spike alerts, workout-focused Fueling Scores, and access to OGDb, which the company describes as the world’s largest open glucose database.

According to Ultrahuman, only one in eight US adults is metabolically healthy, contributing to conditions such as Type 2 diabetes and cardiovascular disease. The company believes that providing real-time metabolic insights can help users make better health decisions before serious health problems develop.

Ultrahuman is also highlighting the scientific foundation behind the platform.

The company says its Metabolic Score has been clinically validated through a multi-center study published in Nature, demonstrating its ability to distinguish between non-diabetic and prediabetic individuals. It also points to recent collaborations with Stanford University, Bangor University, La Trobe University, and the Mayo Clinic as part of its broader metabolic health research efforts.

The launch comes at a time when consumer health technology is rapidly moving beyond simple fitness tracking and into deeper health monitoring. As over-the-counter continuous glucose monitors become more widely available, platforms like M2 Live could help bring metabolic health tracking to a much broader audience.

Ultrahuman says M2 Live will be available in the US through its website in the coming weeks. Each Lingo sensor can be worn for up to 14 days, giving users continuous access to glucose data and personalized health insights throughout the day.